“Monoclonal antibody against CGRP (TEV-48125) for preventive treatment of episodic cluster headache: a phase II randomized clinical trial protocol”, PPCR, vol. 4, no. 1, pp. 14–20, Jul. 2018, Accessed: Nov. 22, 2024. [Online]. Available: https://journal.ppcr.org/index.php/ppcrjournal/article/view/53